Invesco Ltd. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$5,127,084
-33.0%
44,199
-32.2%
0.00%
-50.0%
Q2 2023$7,655,419
+85.4%
65,208
+26.4%
0.00%
+100.0%
Q1 2023$4,129,495
+85.9%
51,580
+83.9%
0.00%0.0%
Q4 2022$2,221,566
-38.2%
28,043
-45.7%
0.00%0.0%
Q3 2022$3,597,000
+499.5%
51,608
+463.8%
0.00%
Q2 2022$600,000
+16.5%
9,154
+18.1%
0.00%
Q1 2022$515,000
-4.3%
7,750
+0.9%
0.00%
Q4 2021$538,000
+26.6%
7,681
-5.6%
0.00%
Q3 2021$425,000
-13.1%
8,136
+12.9%
0.00%
Q2 2021$489,000
+69.2%
7,205
+92.1%
0.00%
Q1 2021$289,000
-80.7%
3,751
-89.2%
0.00%
-100.0%
Q1 2020$1,501,000
-67.1%
34,701
-57.9%
0.00%0.0%
Q4 2019$4,560,000
+178.0%
82,333
+74.4%
0.00%
Q3 2019$1,640,000
+67.5%
47,210
+0.2%
0.00%
Q4 2018$979,00047,1130.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q1 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders